Pfizer
Raghuram Prabhala currently serves as Director of Identity and Platforms at Pfizer, where responsibilities include overseeing multiple initiatives in Developer Products and Platform, focusing on Infrastructure Provisioning, Cloud Cost optimizations, and API management. Notable achievements include developing a next-generation User Provisioning Application, utilizing the open-source BPMN workflow engine Zeebe, and creating an Entitlement Repository Application. Previously, Raghuram held the position of Vice President at Goldman Sachs, acting as a subject matter expert in Identity and Access Management, and architecting an External Authentication system based on OIDC/OAuth 2. Earlier career experience includes serving as Senior Manager at CSC, where Raghuram led the development of a large portal application and architected a claim-based wireless application using J2EE technology. Raghuram holds a Master's Degree from the Indian Institute of Technology, Roorkee.
This person is not in any teams
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.